Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GE vs GSK✓SelectedUSD · GSKGE vs GSK performance historyLatest closeAs of-2.81%11/19
Stock and ETF performance explorer

GE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+424.8%
GSK return
+39.6%
Excess return
+385.3%
Maximum drawdown
-40.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.8%-1.6%-1.2%-2.4%
7D-3.6%-4.7%+1.1%-2.5%
30D+6.3%-4.7%+11.0%+7.5%
3M-10.3%-8.8%-1.6%-8.5%
6M+12.1%-4.6%+16.7%+12.9%
YTD+4.0%+1.0%+3.0%+3.6%
1Y+6.6%+6.9%-0.3%+4.9%
3Y+238.9%+52.5%+186.4%+198.7%
5Y+424.8%+40.3%+384.5%+336.5%
All+424.8%+39.6%+385.3%+336.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling